153 related articles for article (PubMed ID: 32661810)
1. TDM-guided medication of polymyxin B in a patient with CRKP-induced bloodstream infection: a case report.
Yu X; Pan J; Zhou Z; Wen X; Dai Y; Lin G; Jiao Z; Zhang C
Eur J Clin Microbiol Infect Dis; 2021 Jan; 40(1):201-204. PubMed ID: 32661810
[TBL] [Abstract][Full Text] [Related]
2. [The efficacy and safety of different antimicrobial regimens in carbapenem-resistant
Sun WM; Zhou H; Shen LS; Yang Q; Ma WJ; Zhou JY
Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):566-571. PubMed ID: 31365977
[No Abstract] [Full Text] [Related]
3. Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections.
Dubrovskaya Y; Chen TY; Scipione MR; Esaian D; Phillips MS; Papadopoulos J; Mehta SA
Antimicrob Agents Chemother; 2013 Nov; 57(11):5394-7. PubMed ID: 23959321
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine.
Satlin MJ; Kubin CJ; Blumenthal JS; Cohen AB; Furuya EY; Wilson SJ; Jenkins SG; Calfee DP
Antimicrob Agents Chemother; 2011 Dec; 55(12):5893-9. PubMed ID: 21968368
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of polymyxin B in an infant with multidrug-resistant Klebsiella pneumoniae bacteremia.
Salvatore CM; Abdelraouf K; Hsing DD; Tam VH
Pediatr Infect Dis J; 2011 Jun; 30(6):537-9. PubMed ID: 21164382
[TBL] [Abstract][Full Text] [Related]
6. Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection.
Liang Q; Huang M; Xu Z
Braz J Infect Dis; 2019; 23(1):60-65. PubMed ID: 30796888
[TBL] [Abstract][Full Text] [Related]
7. A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.
Xiao T; Zhu Y; Zhang S; Wang Y; Shen P; Zhou Y; Yu X; Xiao Y
J Infect Dis; 2020 Mar; 221(Suppl 2):S174-S183. PubMed ID: 32176799
[TBL] [Abstract][Full Text] [Related]
8. Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection.
Lee J; Patel G; Huprikar S; Calfee DP; Jenkins SG
J Clin Microbiol; 2009 May; 47(5):1611-2. PubMed ID: 19261795
[No Abstract] [Full Text] [Related]
9. Emergence of polymyxin B resistance in a polymyxin B-susceptible KPC-producing Klebsiella pneumoniae causing bloodstream infection in a neutropenic patient during polymyxin B therapy.
Zavascki AP; Girardello R; Magagnin CM; Antochevis LC; Maciel RA; Palmeiro JK; Gales AC
Diagn Microbiol Infect Dis; 2018 Feb; 90(2):134-138. PubMed ID: 29150371
[TBL] [Abstract][Full Text] [Related]
10. Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.
Jacobs DM; Safir MC; Huang D; Minhaj F; Parker A; Rao GG
Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):76. PubMed ID: 29178957
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of NDM-1 Klebsiella pneumoniae bacteraemia in a neutropenic patient.
Chien JM; Koh TH; Chan KS; Chuah TH; Tan TT
Scand J Infect Dis; 2012 Apr; 44(4):312-4. PubMed ID: 22126430
[TBL] [Abstract][Full Text] [Related]
12. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan.
Nadkarni AS; Schliep T; Khan L; Zeana CB
Am J Infect Control; 2009 Mar; 37(2):121-6. PubMed ID: 19249638
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of ceftazidime-resistant Klebsiella pneumoniae ventriculitis with intravenous meropenem and intraventricular polymyxin B: case report and review.
Segal-Maurer S; Mariano N; Qavi A; Urban C; Rahal JJ
Clin Infect Dis; 1999 May; 28(5):1134-8. PubMed ID: 10452648
[TBL] [Abstract][Full Text] [Related]
14. In-vivo emergence of polymyxin- B-resistant Klebsiella pneumoniae in patients with bloodstream infections.
Braun G; Cayô R; Barbosa AC; Gales AC
J Hosp Infect; 2016 Dec; 94(4):338-340. PubMed ID: 27686265
[No Abstract] [Full Text] [Related]
15. Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin.
Humphries RM; Kelesidis T; Dien Bard J; Ward KW; Bhattacharya D; Lewinski MA
J Med Microbiol; 2010 Nov; 59(Pt 11):1383-1386. PubMed ID: 20688947
[TBL] [Abstract][Full Text] [Related]
16. Intraventricular or intrathecal polymyxin B for treatment of post-neurosurgical intracranial infection caused by carbapenem-resistant gram-negative bacteria: a 8-year retrospective study.
Hu Y; Li D; Zhang G; Dai Y; Chen M; Jiang H; Cui W
Eur J Clin Microbiol Infect Dis; 2024 May; 43(5):875-884. PubMed ID: 38443737
[TBL] [Abstract][Full Text] [Related]
17. BL02, a phage against carbapenem- and polymyxin-B resistant Klebsiella pneumoniae, isolated from sewage: A preclinical study.
Liang Z; Shi YL; Peng Y; Xu C; Zhang C; Chen Y; Luo XQ; Li QM; Zhao CL; Lei J; Yuan ZQ; Peng YZ; Song BQ; Gong YL
Virus Res; 2023 Jul; 331():199126. PubMed ID: 37105436
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in haematological malignances and hematopoietic stem cell transplantation: Clinical impact of combination therapy in a 10-year Brazilian cohort.
de Souza ILA; Cappellano P; Ferreira DB; Bergamasco MD; das Chagas Neto TC; Kerbauy FR; Baiocchi OCG; Pignatari ACC
PLoS One; 2024; 19(1):e0297161. PubMed ID: 38277372
[TBL] [Abstract][Full Text] [Related]
19. Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae among intensive care unit patients after orthotopic liver transplantation: risk factors for infection and impact of resistance on outcomes.
Mouloudi E; Massa E; Papadopoulos S; Iosifidis E; Roilides I; Theodoridou T; Piperidou M; Orphanou A; Passakiotou M; Imvrios G; Fouzas I; Papanikolaou V; Gritsi-Gerogianni N
Transplant Proc; 2014 Nov; 46(9):3216-8. PubMed ID: 25420863
[TBL] [Abstract][Full Text] [Related]
20. Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae, São Paulo, Brazil.
Bartolleti F; Seco BM; Capuzzo Dos Santos C; Felipe CB; Lemo ME; Alves Tda S; Passadore LF; Mimica MJ; Sampaio SC; Zavascki AP; Sampaio JL
Emerg Infect Dis; 2016 Oct; 22(10):1849-51. PubMed ID: 27648951
[No Abstract] [Full Text] [Related]
[Next] [New Search]
